Back to Rankings

CGEN

CompugenA
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
Above peers
vs peer average
CGEN vs peer average
89/100
CGEN vs. peer average (A vs. C)
Grade spread
A 2 · B 1 · C 2 · D 2 · F 4
Graded peers loaded
Coverage
11 graded
100% of tracked

Peer overview

TRDA is the first available peer comparator.

Comparable mainly on size and event-driven biotech dynamics; it offers sentiment context more than direct revenue or margin comparison.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerTRDAEntrada Therapeutics
CGEN
Compugen
TRDA
Entrada Therapeutics
Grade
A
F
Momentum
89
1
Value
47
58
Sentiment
95
59
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Defensive

Grade position vs TRDA

CGEN / TRDA
Grade Position
Above peers
CGEN vs. peer average (A vs. C)
89/100
Momentum
89
CGEN
Value
47
TRDA
Sentiment
95
CGEN

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs CGEN
1
TRDA
TRDA
F
20/100
+4
2
ALXO
ALXO
F
20/100
+4
3
CLLS
CLLS
A
100/100
Even
4
LENZ
LENZ Therapeutics Inc Common
D
40/100
+3
5
FHTX
Foghorn Therapeutics Inc Common
C
60/100
+2
TRDA is the first peer returned for this comparison set.